Healthcare-Focused High Schools Boost Career Mobility and Address Workforce Crises

Catapult Solutions Group Banner Ad

In an innovative stride towards bridging the gap between education and career readiness, Bloomberg Philanthropies has initiated a pioneering project to integrate healthcare training within high school curricula across several American communities. This $250 million investment aims to cultivate a new generation of healthcare professionals by creating healthcare-focused high schools in collaboration with major healthcare systems and public education sectors. These schools will provide students not only with a traditional academic education but also with specialized healthcare training and certifications, preparing them for immediate employment or further education in the healthcare industry.

Amidst this transformative educational landscape, how can such initiatives significantly enhance the career trajectories and life outcomes of students?

Geoffrey M Roche, a healthcare executive advisor and expert in healthcare administration, shares his thoughts on the significant impact that healthcare-focused educational programs can have on advancing student careers and improving societal health. He highlights how these programs can create career paths, provide immediate employment opportunities, and help address the ongoing workforce shortages in healthcare.

“When we think about this for the students, the opportunity they have to grow and have this experience is truly about mobility. They have the opportunity to learn healthcare in high school and to potentially earn certifications and grow further into a healthcare career,” Roche said.

Article by Sonia Gossai

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More